Wall Street set the tone for the Asian trading session

Michael Daniell has won the New Zealand Shareholders Association's 2016 Beacon Award

Fisher & Paykel Healthcare, the medical device maker, increased first-half profit 26 per cent and widened its margins.

F&P Healthcare has filed a patent infringement lawsuit against ResMed, claiming it used its tech in its breathing masks and air flow products.

Details of the case against Milford Asset Management's Mark Warminger were revealed in court today.

Fisher & Paykel Healthcare beat its forecast for annual profit, boosting revenue and margins.

Henri Eliot talks publishing a skills matrix that provides shareholders with the information needed to evaluate a board's skill set mix.

Brokers are picking Fisher & Paykel Healthcare, Diligent and Infratil to be among the NZX's top-performing stocks in 2016.

Henri Eliot talks to professional directors Mark Verbiest, Tony Carter, Doug McKay and Rob Campbell about their focal points in 2016.

The departure of Fisher & Paykel Healthcare chief executive Mike Daniell might unsettle some investors but is unlikely to derail the company, say market players.

F&P Healthcare's boss Mike Daniell says he'll retire this year, as the company announces an upgrade to its earnings guidance.

When people talk about the New Zealand health technology sector, they tend to think about two companies - Orion Health and Fisher & Paykel Healthcare.

Fisher & Paykel Healthcare reported yet another record full-year profit last Friday, justifying Craigs' consistently bullish view.

Fisher & Paykel Healthcare beat its forecast annual profit and said earnings would rise further in the coming year.

Fisher & Paykel Healthcare could beat its own guidance for a record-breaking annual profit when its full-year result is revealed on Friday, a broker says.

New Zealand shares fell for a second day as the kiwi dollar's slide to a four-year low sapped overseas investor appetite for high-yielding stocks.

New Zealand shares rose as Fisher & Paykel Healthcare advanced to a record after lifting its annual profit guidance. Xero fell as its first-half results showed a slower pace of growth.

Fisher & Paykel Healthcare shares have soared to a record high after the medical device maker's sixth profit guidance upgrade in two years.

Check out a snapshot of some of the stellar performers on the New Zealand sharemarket this year, as it surged ahead breaking new records.

NZ exporters will have better access to up to more than $2 trillion worth of government contracts, with a trade deal signed two years ago expected to come into force soon.

Fisher & Paykel Healthcare has become a $3 billion company after its ballooning share price hit a record high.

The 300-strong, record turnout at last weekend's Shareholders Association annual conference helped illustrate a major challenge facing the local sharemarket.

Technology has come a long way since Fisher & Paykel Healthcare made its first air humidifier prototype using an AG preserving jar and the company is working hard to stay at the forefront of respiratory technology.

Innovation is continuing to bolster Fisher & Paykel Healthcare's business in the face of a stubbornly high New Zealand dollar, says chief executive Mike Daniell.

The contrasting fortunes of two of New Zealand's biggest technology manufacturers were highlighted when they both reported full-year results yesterday.

Fisher & Paykel Healthcare, which makes breathing masks and respirators, expects to beat analyst expectations for 2014 profit as it surpassed its own guidance for 2103 profit today.